Latest Commercialization News

Brazilian Rare Earths Limited (BRE) reports a robust scoping study for its Amargosa Bauxite-Gallium Project, alongside a strategic heavy rare earths partnership and a strong cash position to accelerate development.

Rimfire Pacific Mining reports promising scandium drilling results at Murga and Rabbit Trap, alongside a significant new gold-antimony discovery at Broken Hill, positioning the company for resource growth and strategic opportunities.

HyTerra Limited has unveiled a comprehensive strategic plan to commercialise its Nemaha Project in Kansas, backed by new leadership and a key US technology partnership. The company is advancing towards production testing in 2026 amid promising hydrogen and helium discoveries.

Saferoads Holdings Limited reported a modest rise in quarterly sales and a half-year net profit of approximately $511k, while progressing regulatory approval for its innovative HV2 barrier.

Viva Energy’s latest quarterly update reveals a modest rise in commercial fuel volumes driven by aviation, while convenience retail sales decline amid store conversions and illicit trade pressures.

Zeotech Limited has made significant strides in advancing its Toondoon Kaolin Project mining readiness and secured key partnerships to commercialise its AusPozz™ metakaolin product, validated by independent testing.

Vitura Health has announced the departure of CEO Geoff Cockerill, appointing Chief Revenue Officer Ryan Tattle as interim leader while accelerating the search for a new CEO. Incoming CFO Andrew Cook will join ahead of schedule, signalling a renewed focus on operational and financial discipline.

Alpha HPA Limited has raised A$225 million in a fully underwritten placement to fund the commercialisation of Stage 2 of its High Purity Alumina project, with strong backing from the National Reconstruction Fund Corporation. This capital injection positions the company to become the world’s largest single-site HPA manufacturer, supporting critical semiconductor supply chains.

BrainChip Holdings has bolstered its financial position with a A$35 million capital raise and commenced volume production of its AKD1500 neuromorphic AI chip, while deepening its strategic partnership with Parsons’ defence arm.

Dimerix Limited has completed recruitment for its pivotal ACTION3 Phase 3 trial targeting a rare kidney disease, secured positive FDA feedback on trial endpoints, and reported a solid cash position of AU$38.5 million at the end of 2025.

OD6 Metals has reported significant progress in its rare earth and copper projects, unveiling a high-recovery processing flowsheet and identifying promising new copper conductors near historic workings.

BetMakers Technology Group reported a robust Q2 FY26 with positive adjusted EBITDA and significant contract wins poised to fuel growth in the second half of the year.